Recombinant VEGF (Bevacizumab Biosimilar) 抗体
Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) 抗体 (ABIN5668151)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
原理
- Anti-VEGF [Bevacizumab], Rabbit IgG, kappa
-
特异性
- This antibody binds native and reduced human VEGF (isoform 165).
-
产品特性
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
纯化方法
- Protein A affinity purified
-
纯度
- > 98 % as determined by SDS-PAGE
-
内毒素水平
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
-
免疫原
- Recombinant human VEGF.
-
亚型
- IgG kappa
-
-
-
-
应用备注
- This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
-
说明
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 0.02 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- VEGF (Bevacizumab Biosimilar)
-
背景
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
-
UniProt
- P15692
抗原
-